Electronic cigarettes: The issues behind the moral quandary

Progress in Respiratory Research

Volumn 42, Issue , 2015, Pages 258-267

  Vardavas, Constantine I ^a,b   Agaku, Israel T ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926314320     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000369506     Document Type: Article

References (69)

1. e-cigarettes: a moral quandary. Lancet 2013; 382: 914.
2. Lopez D, Collishaw NE, Piha T: A descriptive model of the cigarette epidemic in developed countries (editorial). Tob Control 1994; 3: 3.
3. Giovino GA: Epidemiology of tobacco use in the United States. Oncogene 2002; 21: 7326-7340.
4. Benowitz NL: Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc 2014; 11: 231-235.
5. Drummond MB, Upson D: Electronic cigarettes-potential harms and benefits. Ann Am Thorac Soc 2014; 11: 236-242.
6. Berridge V: Electronic cigarettes and history. Lancet 2014; 383: 2204-2205.
7. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H: Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res 2014, Epub ahead of print.
8. Zhang Y, Sumner W, Chen DR: In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res 2013; 15: 501-508.
9. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013; 15: 158-166.
10. Trtchounian A, Williams M, Talbot P: Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010; 12: 905-912.
11. Vansickel AR, Eissenberg T: Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013; 15: 267-270.
12. Schripp T, Markewitz D, Uhde E, Salthammer T: Does e-cigarette consumption cause passive vaping Indoor Air 2013; 23: 25-31.
13. Uchiyama S, Ohta K, Inaba Y, Kunugita N: Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2, 4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci 2013; 29: 1219-1222.
14. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, Goniewicz ML: Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16: 1319-1326.
15. Carpenter CM, Wayne GF, Connolly GN: The role of sensory perception in the development and targeting of tobacco products. Addiction 2007; 102: 136-147.
16. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V: Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health 2013; 10: 7272-7282.
17. Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, Westenberger BJ: Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol 2011; 34: 1442-1458.
18. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P 3rd, Benowitz N: Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23: 133-139.
19. Wieslander G, Norback D, Lindgren T: Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001; 58: 649-655.
20. Chen IL: FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res 2013; 15: 615-616.
21. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y: Acute impact of active and passive cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013; 25: 91-101.
22. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK: Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141: 1400-1406.
23. Vakali S, Tsikrika S, Gennimata S, Kaltsakas G, Palamidas A, Koulouris A, Gratziou C: E-Cigarette acute effect on symptoms and airway inflammation: comparison of nicotine with a non-nicotine cigarette. Tob Induc Dis 2014; 12(suppl 1):A35.
24. Tsikrika S, Vakali S, Gennimata S, Palamidas A, Kaltsakas G, Koulouris N, Gratziou C: Short term use of an e-cig: influence on clinical symptoms, vital signs and eCO levels. Tob Induc Dis 2014; 12(suppl 1):A30.
25. Lim HB, Kim SH: Inhalation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice. Toxicol Res 2014; 30: 13-18.
26. Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y: Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012; 50: 3600-3603.
27. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P: Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34: 529-537.
28. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE: Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013; 25: 354-361.
29. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V: Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013; 10: 5146-5162.
30. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M: Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; 23(suppl 3):iii3-iii9.
31. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P: Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8:e57987.
32. Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A: Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res 2014; 16: 655-662.
33. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A: Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol 2014; 88: 1295-1308.
34. Bjartveit K, Tverdal A: Health consequences of smoking 1-4 cigarettes per day. Tob Control 2005; 14: 315-320.
35. Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL: Does dual use jeopardize the potential role of smokeless tobacco in harm reduction Nicotine Tob Res 2010; 12: 1055-1067.
36. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013; 8:e66317.
37. Orr KK, Asal NJ: Efficacy of electronic cigarettes for smoking cessation. Ann Pharmacother 2014; 48: 1502-1506.
38. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N: Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629-1637.
39. Brown J, Beard E, Kotz D, Michie S, West R: Realworld effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109: 1531-1540.
40. Vardavas CI, Filippidis FT, Agaku IT: Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 countries. Tob Control 2014, Epub ahead of print.
41. Grana R, Benowitz N, Glantz SA: E-cigarettes: a scientific review. Circulation 2014; 129: 1972-1986.
42. IOM (Institute of Medicine): Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, The National Academies Press, 2012.
43. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA: Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health 2013; 103:e57-e62.
44. Choi K, Forster JL: Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. Am J Prev Med 2014; 46: 175-178.
45. Dockrell M, Morrison R, Bauld L, McNeill A: Ecigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013; 15: 1737-1744.
46. Kandel ER, Kandel DB: Shattuck Lecture. A molecular basis for nicotine as a gateway drug. N Engl J Med 2014; 371: 932-943.
47. Bunnell RE, Agaku IT, Arrazola RA, Apelberg BJ, Caraballo RS, Corey CG, Coleman BN, Dube SR, King BA: Intentions to smoke cigarettes among never-smoking U.S. middle and high school electronic cigarette users, National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res 2014, Epub ahead of print.
48. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB: e-cigarette awareness, use, and harm perceptions in US adults. Am J Public Health 2012; 102: 1758-1766.
49. Regan AK, Promoff G, Dube SR, Arrazola R: Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob Control 2013; 22: 19-23.
50. Dutra LM, Glantz SA: Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatr 2014; 168: 610-617.
51. King BA, Alam S, Promoff G, Arrazola R, Dube SR: Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res 2013; 15: 1623-1627.
52. Lee S, Grana RA, Glantz SA: Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health 2014; 54: 684-690.
53. Frieden T: E-Cigarette Use More than Doubles among U.S. Middle and High School Students from 2011-2012. Atlanta, Centers for Disease Control and Prevention, 2013, http://www.cdc.gov/media/releases/2013/p0905-ecigarette-use.html.
54. Blasi F, Ward B: Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning Eur Respir J 2014; 44: 585-588.
55. King AC, Smith LJ, McNamara PJ, Matthews AK, Fridberg DJ: Passive exposure to electronic cigarette (e-cigarette) use increases desire for combustible and e-cigarettes in young adult smokers. Tob Control 2014, Epub ahead of print.
56. Vakkalanka JP, Hardison LS Jr, Holstege CP: Epidemiological trends in electronic cigarette exposures reported to U.S. Poison Centers. Clin Toxicol (Phila) 2014; 52: 542-548.
57. Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, Apelberg B, Schier JG; Centers for Disease Control and Prevention (CDC): Notes from the field: calls to poison centers for exposures to electronic cigarettes-United States, September 2010-February 2014. MMWR Morb Mortal Wkly Rep 2014; 63: 292-293.
58. US Department of Health and Human Services: The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
59. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jorres RA, Fromme H: Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health 2014; 217: 628-637.
60. Ballbè M, Martínez-Sánchez JM, Sureda X, Fu M, Pérez-Ortunõ R, Pascual JA, Saltó E, Fernández E: Cigarettes vs e-cigarettes: passive exposure at home measured by means of airborne marker and biomarkers. Environ Res 2014; 135C:76-80.
61. Goniewicz ML, Lee L: Electronic cigarettes are a source of thirdhand exposure to nicotine. Nicotine Tob Res 2014, Epub ahead of print.
62. Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, Sansores R, Van Zyl-Smit R; Forum of International Respiratory Societies: Electronic cigarettes. A position statement of the Forum of International Respiratory Societies. Am J Respir Crit Care Med 2014; 190: 611-618.
63. Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, Robertson RM, McAuley T, Goff D, Benowitz N; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Quality of Care and Outcomes Research: Electronic cigarettes: a policy statement from the American Heart Association. Circulation 2014; 130: 1418-1436.
64. Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW: Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol 2015; pii:JCO.2014.59.4465. [Epub ahead of print].
65. WHO Framework Convention on Tobacco Control: Sixth Session. Moscow, Russian Federation, 13-18 October 2014. Decision: Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems. http://apps.who.int/gb/fctc/PDF/cop6/FCTC-COP6(9)-en.pdf.
66. Grana RA, Ling PM: 'Smoking revolution': a content analysis of electronic cigarette retail websites. Am J Prev Med 2014; 46: 395-403.
67. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014, The approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC Text with EEA relevance. http://eur-lex. europa.eu/legal-content/EN/TXT/qid=13987613 79066&uri=OJ:JOL-2014-127-R-0001.
68. Orleans CT, Slade J: Nicotine Addiction: Principles and Management. New York, Oxford University Press, 2002.
69. Bertholon JF, Becquemin MH, Annesi-Maesano I, Dautzenberg B: Electronic cigarettes: a short review. Respiration 2013; 86: 433-438.